Published in Circulation on June 03, 1997
Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg (2000) 2.09
Adenosine receptor-mediated adhesion of endothelial progenitors to cardiac microvascular endothelial cells. Circ Res (2007) 1.65
A3 adenosine receptor agonist IB-MECA reduces myocardial ischemia-reperfusion injury in dogs. Am J Physiol Heart Circ Physiol (2003) 1.17
Cardiac repair and regeneration: the Rubik's cube of cell therapy for heart disease. Dis Model Mech (2009) 1.16
Adenosine myocardial protection: preliminary results of a phase II clinical trial. Ann Surg (1999) 1.03
Overexpression of A(3) adenosine receptors decreases heart rate, preserves energetics, and protects ischemic hearts. Am J Physiol Heart Circ Physiol (2002) 1.03
Pharmacological and ischemic preconditioning of the human myocardium: mitoK(ATP) channels are upstream and p38MAPK is downstream of PKC. BMC Physiol (2002) 0.92
Stem cell therapy: pieces of the puzzle. J Cardiovasc Transl Res (2009) 0.91
Therapeutic receptor targets of ischemic preconditioning. Cardiovasc Res (2002) 0.89
Intravenous adenosine protects the myocardium primarily by activation of a neurogenic pathway. Br J Pharmacol (2005) 0.87
Left ventricular function and cardiovascular events following adjuvant therapy with adenosine in acute myocardial infarction treated with thrombolysis, results of the ATTenuation by Adenosine of Cardiac Complications (ATTACC) study. Eur J Clin Pharmacol (2003) 0.85
Partial hindlimb occlusion reduced the susceptibility to sustained ventricular tachycardia in conscious rats. J Cardiovasc Pharmacol Ther (2009) 0.83
Therapeutic potential of ischaemic preconditioning. Br J Clin Pharmacol (2000) 0.82
Does adenosine prevent myocardial micronecrosis following percutaneous coronary intervention? The ADELINE pilot trial. ADEnosine Limit myocardial Necrosis. Heart (2002) 0.80
Electroacupuncture at PC6 (Neiguan) Improves Extracellular Signal-Regulated Kinase Signaling Pathways Through the Regulation of Neuroendocrine Cytokines in Myocardial Hypertrophic Rats. Evid Based Complement Alternat Med (2011) 0.80
Cardioprotection acquired through exercise: the role of ischemic preconditioning. Curr Cardiol Rev (2014) 0.79
Does a selective adenosine A(1) receptor agonist protect against exercise induced ischaemia in patients with coronary artery disease? Heart (2002) 0.79
Pharmacological modulation of the ATP sensitive potassium channels during repeated coronary occlusions: no effect on myocardial ischaemia or function. Heart (2004) 0.79
The role of free radicals in endogenous adaptation and intracellular signals. Exp Clin Cardiol (2004) 0.78
Adenosine and ischemic preconditioning. Curr Pharm Des (1999) 0.77
Protection Conferred by Preinfarct Angina is Manifest in the Aged Heart: Evidence from the TIMI 4 Trial. J Thromb Thrombolysis (1998) 0.77
Pharmacological postconditioning with diazoxide attenuates ischemia/reperfusion-induced injury in rat liver. Exp Ther Med (2013) 0.77
Adenosine pretreatment of human myocardium and ischemic preconditioning. Circulation (1998) 0.75
An electrocardiographic sign of ischemic preconditioning. Am J Physiol Heart Circ Physiol (2014) 0.75
Mechanisms of cell death in acute myocardial infarction: pathophysiological implications for treatment. Neth Heart J (2001) 0.75
Oral nicorandil recaptures the waned protection from preconditioning in vivo. Br J Pharmacol (2003) 0.75
Ischaemic preconditioning and myocardial adaptation to serial intracoronary balloon inflation: cut from the same cloth? Heart (2004) 0.75
Adenosine-induced preconditioning of human myocardium? Circulation (1998) 0.75
Comparative genomics of the lactic acid bacteria. Proc Natl Acad Sci U S A (2006) 10.24
Degradation of polychlorinated biphenyls by two species of Achromobacter. Can J Microbiol (1973) 7.70
The late phase of ischemic preconditioning is abrogated by targeted disruption of the inducible NO synthase gene. Proc Natl Acad Sci U S A (1999) 3.32
Opposing cardioprotective actions and parallel hypertrophic effects of delta PKC and epsilon PKC. Proc Natl Acad Sci U S A (2001) 3.28
Demonstration of an early and a late phase of ischemic preconditioning in mice. Am J Physiol (1998) 3.11
Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology (1996) 2.99
Influence of coronary collateral vessels on myocardial infarct size in humans. Results of phase I thrombolysis in myocardial infarction (TIMI) trial. The TIMI Investigators. Circulation (1991) 2.33
Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits. Proc Natl Acad Sci U S A (2000) 2.28
Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction: results of a multicenter, randomized, placebo-controlled trial: the Acute Myocardial Infarction STudy of ADenosine (AMISTAD) trial. J Am Coll Cardiol (1999) 2.23
The nitric oxide hypothesis of late preconditioning. Basic Res Cardiol (1998) 2.19
Clinical profile and outcome of swine flu in Indian children. Indian Pediatr (2010) 2.14
Medical and cellular implications of stunning, hibernation, and preconditioning: an NHLBI workshop. Circulation (1998) 1.96
Delayed preconditioning-mimetic action of nitroglycerin in patients undergoing coronary angioplasty. Circulation (2001) 1.91
Nitric oxide synthase is the mediator of late preconditioning against myocardial infarction in conscious rabbits. Circulation (1998) 1.90
Causes and outcome of young infant admissions to a Kenyan district hospital. Arch Dis Child (2003) 1.81
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis. Lancet (1996) 1.78
Nuclear factor-kappaB plays an essential role in the late phase of ischemic preconditioning in conscious rabbits. Circ Res (1999) 1.75
An essential role of the JAK-STAT pathway in ischemic preconditioning. Proc Natl Acad Sci U S A (2001) 1.73
Spontaneous delayed recovery of perfusion and contraction after the first 5 weeks after anterior infarction. Evidence for the presence of hibernating myocardium in the infarcted area. Circulation (1994) 1.68
Epidemiology of cystic fibrosis-related diabetes. J Pediatr (2005) 1.66
Internal olefins to linear amines. Science (2002) 1.64
Functional proteomic analysis of protein kinase C epsilon signaling complexes in the normal heart and during cardioprotection. Circ Res (2001) 1.59
A simple technique of umbilical port closure in laparoscopic cholecystectomy. Ann R Coll Surg Engl (1993) 1.56
Prevalence and diagnostic significance of fluid-fluid levels in soft-tissue neoplasms. Clin Radiol (2007) 1.56
Enhancement of recovery of myocardial function by oxygen free-radical scavengers after reversible regional ischemia. Circulation (1985) 1.54
Radio-frequency thermal ablation with NaCl solution injection: effect of electrical conductivity on tissue heating and coagulation-phantom and porcine liver study. Radiology (2001) 1.53
Evidence for an essential role of reactive oxygen species in the genesis of late preconditioning against myocardial stunning in conscious pigs. J Clin Invest (1996) 1.52
Prostatic infarction/infection in acute urinary retention secondary to benign prostatic hyperplasia. J Urol (1998) 1.49
Thalidomide in Crohn disease and the risk of peripheral neuropathy. J Pediatr Gastroenterol Nutr (2003) 1.49
Isoform-selective activation of protein kinase C by nitric oxide in the heart of conscious rabbits: a signaling mechanism for both nitric oxide-induced and ischemia-induced preconditioning. Circ Res (1999) 1.48
Direct in vivo gene transfer into porcine myocardium using replication-deficient adenoviral vectors. Circulation (1994) 1.45
Gene therapy with bilirubin-UDP-glucuronosyltransferase in the Gunn rat model of Crigler-Najjar syndrome type 1. Hum Gene Ther (1998) 1.44
Amoebic appendicitis--a rare entity. J Pak Med Assoc (1994) 1.42
A(1) or A(3) adenosine receptors induce late preconditioning against infarction in conscious rabbits by different mechanisms. Circ Res (2001) 1.40
Nitric oxide triggers late preconditioning against myocardial infarction in conscious rabbits. Am J Physiol (1997) 1.39
Nitric oxide donors induce late preconditioning against myocardial stunning and infarction in conscious rabbits via an antioxidant-sensitive mechanism. Circ Res (1998) 1.39
Direct evidence that protein kinase C plays an essential role in the development of late preconditioning against myocardial stunning in conscious rabbits and that epsilon is the isoform involved. J Clin Invest (1998) 1.39
Anti-inflammatory activity of a lipid fraction (lyprinol) from the NZ green-lipped mussel. Inflammopharmacology (1997) 1.38
Transgenic overexpression of constitutively active protein kinase C epsilon causes concentric cardiac hypertrophy. Circ Res (2000) 1.37
Cell therapy for ischaemic heart disease: focus on the role of resident cardiac stem cells. Neth Heart J (2009) 1.35
PKC-dependent activation of p44/p42 MAPKs during myocardial ischemia-reperfusion in conscious rabbits. Am J Physiol (1999) 1.35
Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits. Am J Physiol Heart Circ Physiol (2000) 1.35
Evidence for an essential role of cyclooxygenase-2 as a mediator of the late phase of ischemic preconditioning in mice. Basic Res Cardiol (2000) 1.31
Reperfusion induced injury: manifestations, mechanisms, and clinical relevance. Cardiovasc Res (1992) 1.30
Induction of the mesendoderm in the zebrafish germ ring by yolk cell-derived TGF-beta family signals and discrimination of mesoderm and endoderm by FGF. Development (1999) 1.28
Demonstration of selective protein kinase C-dependent activation of Src and Lck tyrosine kinases during ischemic preconditioning in conscious rabbits. Circ Res (1999) 1.28
Enhanced PKC beta II translocation and PKC beta II-RACK1 interactions in PKC epsilon-induced heart failure: a role for RACK1. Am J Physiol Heart Circ Physiol (2001) 1.27
Bifunctional role of protein tyrosine kinases in late preconditioning against myocardial stunning in conscious rabbits. Circ Res (2000) 1.26
Activation of the complement system by recombinant tissue plasminogen activator. J Am Coll Cardiol (1987) 1.25
Urinary tract pathogens and resistance pattern. J Clin Pathol (2010) 1.24
Antimicrobial susceptibilities and plasmid contents of Neisseria gonorrhoeae isolates from commercial sex workers in Dhaka, Bangladesh: emergence of high-level resistance to ciprofloxacin. J Clin Microbiol (1999) 1.24
The importance of seeking ALMS1 mutations in infants with dilated cardiomyopathy. J Med Genet (2005) 1.23
Long-arm deletion of 19-20 chromosomes. Lancet (1972) 1.23
Electron microscopic localization of herpesvirus-type particles in Marek's disease. J Virol (1968) 1.22
Late preconditioning against myocardial stunning. An endogenous protective mechanism that confers resistance to postischemic dysfunction 24 h after brief ischemia in conscious pigs. J Clin Invest (1995) 1.21
Gene therapy with extracellular superoxide dismutase protects conscious rabbits against myocardial infarction. Circulation (2001) 1.19
Progressive myoclonus epilepsy with polyglucosans (Lafora disease): evidence for a third locus. Neurology (2004) 1.17
Attenuation of dysfunction in the postischemic 'stunned' myocardium by dimethylthiourea. Circulation (1987) 1.17
A sustainable community-based arsenic mitigation pilot project in Bangladesh. Int J Environ Health Res (2001) 1.17
Targeted deletion of the A3 adenosine receptor confers resistance to myocardial ischemic injury and does not prevent early preconditioning. J Mol Cell Cardiol (2001) 1.17
Molecular analysis of the high-hemoglobin-F phenotype in Saudi Arabian sickle cell anemia. N Engl J Med (1987) 1.17
High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J Hepatol (1999) 1.17
The epidemiology and spectrum of surgical care in district hospitals of Pakistan. Am J Public Health (1987) 1.16
PKCepsilon activation induces dichotomous cardiac phenotypes and modulates PKCepsilon-RACK interactions and RACK expression. Am J Physiol Heart Circ Physiol (2001) 1.15
Metal binding specificity in carbonic anhydrase is influenced by conserved hydrophobic core residues. Biochemistry (1999) 1.15
Demonstration of free radical generation in the "stunned" myocardium in the conscious dog and identification of major differences between conscious and open-chest dogs. J Clin Invest (1993) 1.14
Combination alpha-interferon and lamivudine therapy for alpha-interferon-resistant chronic hepatitis B infection: results of a pilot study. J Hepatol (1998) 1.14
C-type virus particles in placentas and fetal tissues of Rhesus monkeys. J Natl Cancer Inst (1973) 1.12
PKCepsilon modulates NF-kappaB and AP-1 via mitogen-activated protein kinases in adult rabbit cardiomyocytes. Am J Physiol Heart Circ Physiol (2000) 1.12
Cardiac-specific abrogation of NF- kappa B activation in mice by transdominant expression of a mutant I kappa B alpha. J Mol Cell Cardiol (2001) 1.11
Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium. Am J Physiol (1987) 1.11
Radioactive seed localization for non-palpable breast cancer (Br J Surg 2013; 100: 582-588). Br J Surg (2013) 1.10
Nitroglycerin induces late preconditioning against myocardial infarction in conscious rabbits despite development of nitrate tolerance. Circulation (2001) 1.09
Effect of inhaled 3% CO2 on Cheyne-Stokes respiration in congestive heart failure. Sleep (1994) 1.09
Production and characterization of a reconstituted high density lipoprotein for therapeutic applications. Vox Sang (1996) 1.08
Acute and long-term effects of octreotide in patients with ACTH-dependent Cushing's syndrome. Am J Med (1993) 1.08
Vascular pedicle graft of the ipsilateral fibula for non-union of the tibia with a large defect. An experimental and clinical study. J Bone Joint Surg Br (1981) 1.08
Primary lymphoma of the ocular adnexa (orbital lymphoma) and primary intraocular lymphoma. Clin Oncol (R Coll Radiol) (2012) 1.08
Oxidation of polychlorinated biphenyls by achromobacter pCB. Bull Environ Contam Toxicol (1973) 1.07
Protein kinase C epsilon-Src modules direct signal transduction in nitric oxide-induced cardioprotection: complex formation as a means for cardioprotective signaling. Circ Res (2001) 1.06
Computer-assisted learning; experience at the Bristol Urological Institute in the teaching of urology. Br J Urol (1997) 1.05
The histopathology of routine tonsillectomy specimens: results of a study and review of literature. Ear Nose Throat J (2000) 1.04
Gene therapy with extracellular superoxide dismutase attenuates myocardial stunning in conscious rabbits. Circulation (1998) 1.04
Re-excision operations in nonpalpable breast cancer. J Surg Oncol (1995) 1.04
Myocardial reperfusion injury: role of oxygen radicals and potential therapy with antioxidants. Am J Cardiol (1994) 1.04
gli, a zinc finger transcription factor and oncogene, is expressed during normal mouse development. Dev Dyn (1993) 1.04
The production of blood cell stasis and endothelial damage in the blood vessels of chick embryos treated with ultrasound in a stationary wave field. Ultrasound Med Biol (1974) 1.04
Sphenoid sinus brown tumor of secondary hyperparathyroidism: case report. Neurosurgery (1998) 1.03
Neurosurgical aspects of sphenoid sinus mucocele. Br J Neurosurg (1998) 1.03
The molecular landscape of ASPM mutations in primary microcephaly. J Med Genet (2008) 1.03
An investigation of current endodontic practice and training needs in primary care in the north west of England. Br Dent J (2009) 1.02
Autonomic innervation of tendons, ligaments and joint capsules. A morphologic and quantitative study in the rat. J Orthop Res (2001) 1.01
The drug-binding activity of the multidrug-responding transcriptional regulator BmrR resides in its C-terminal domain. J Bacteriol (1996) 1.01
Microsurgery versus standard removal of the herniated lumbar disc. A 3-year comparison in 150 cases. Acta Orthop Scand (1990) 1.01
Overexpression of the normal phosphoribosylpyrophosphate synthetase 1 isoform underlies catalytic superactivity of human phosphoribosylpyrophosphate synthetase. J Biol Chem (1996) 1.00
Potency of wild-type and temperature-sensitive vesicular stomatitis virus matrix protein in the inhibition of host-directed gene expression. Virology (1996) 1.00